Research Advisory Council


Research Advisory Council (RAC)

PCC is advised and counseled by a Research Advisory Council (RAC) that comprises prominent prostate cancer researchers. The role of RAC is to:
  • Synthesize the results of the peer review process and make recommendations for funding to senior PCC staff
  • Receive reports of the evaluation of PCC research programs and provide advice on the development of new programs and the ongoing improvements to existing programs
  • Lead the identification of strategic research areas that could be targeted with specific Requests For Applications
  • Evaluate the PCC peer review processes and recommend necessary enhancements on an ongoing basis
  • Recommend membership of peer review panels
  • Identify potential national and international opportunities for collaboration
  • Provide advice in the development and refinements of scientific and administrative policies
The Council will be composed of established prostate cancer researchers who:
  • Collectively represent expertise in all areas of prostate cancer research
  • Are broadly representative of all major regions in Canada
  • Individually have a strong track record in peer-reviewed research funding and research output

In addition, the Council will include 2 non-scientific members, one of whom must be a prostate cancer patient or survivor. Each will be identified and selected through a formal nomination process.

Current Membership

Steve Belway, Community Representative, Calgary
Robert Bristow (Scientific Chair), University Hospital Network, Toronto
Michael Brundage, Queens University, Kingston
Kerry Courneya, University of Alberta, Edmonton
Juanita Crook, BC Cancer Agency, Kelowna
Jim Davie, University of Manitoba, Winnipeg
Stuart Edmonds (Ex Officio), Prostate Cancer Canada, Toronto
Aaron Fenster, Robarts Research Institute, London

Carolyn Gotay, University of British Columbia, Vancouver
Martin Gleave, Vancouver Prostate Centre, Vancouver

Winston Klass, Community Representative, Concord
John Lewis, University of Alberta, Edmonton
William Nelson, Johns Hopkins Medicine, Baltimore

John Oliffe, University of British Columbia, Vancouver
Marie-Elise Parent, INRS–Institut Armand-Frappier Research Centre, Laval
Fred Saad, Université de Montréal, Montreal
Gurmit Singh, McMaster University, Hamilton

John Valliant, McMaster University, Hamilton

As of June 5, 2015

Subscribe to our free monthly e-newsletter!

* indicates required


PCC Spotlight
Hockey Fights Cancer Teams Up with Prostate Cancer Canada

Toronto – November 2nd, 2015 – Prostate Cancer Canada (PCC) is proud to be an official charitable partner in the 17th annual Hockey Fights Cancer™ (HFC) campaign.

Virus vs. Prostate Cancer: Canadian Researchers Pioneer Next-generation Therapy

Toronto –September 30, 2015 – A multi-disciplinary team of scientists and clinicians led by Dr.

Prostate Cancer Canada and the Movember Foundation partner to support research into better care and support for those living with the disease

September 1, 2015 – Toronto, ON – September is Prostate Cancer Awareness Month, an important time to reflect on the disease that affects one in eight Canadian men in their lifetime and kills 4,100, this year.

Prostate Cancer Canada Announces New Additions to its Board of Directors

TORONTO, ON - JULY 8th 2015 - Prostate Cancer Canada is pleased to announce the election of 5 new members to the PCC Board of Directors.

Prostate Cancer Canada Celebrates Wear Plaid for Dad Winner

JULY 8TH, 2015 - TORONTO, ON - Prostate Cancer Canada is thrilled to announce Borden Ladner Gervais (BLG) as the first-ever Wear Plaid for Dad National Workplace Champion.

Click here for news archive